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CLINICAL STUDIES / ETUDES CLINIQUES
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RESUME
Introduction 
L’étude a pour but d’apprécier les manifestations ophtalmologiques des patients présentant des tumeurs 
cérébrales au Nigéria dans un hôpital tertiaire.
Méthode 
Il s’agit d’une étude rétrospective avec une revue des tumeurs cérébrales dans le Neurosurgical Unit of 
Obafemi  Awolowo University Teaching Hospitals  Complex,  Ile-  Ife  de janvier  2003 à  décembre  2007. 
L’analyse  des  données,  diagnostique,  acuité  visuelle,  et  prise  en  charge,  ont  été  analysées  selon  la 
fréquence en utilisant avec la version 1 11 SPCS . L’acuité visuelle a été classifiée selon celle de l’OMS.
Résultat 
Sur un total de 94 patients, 88 patients ont été revus. Il s’agissait de 53 patients de sexe masculin et 35 de 
sexe féminin. La moyenne d’âge était de 36.2 plus ou moins 20 ans. 14 patients ont été pris en charge par 
les  ophtalmologistes.  La  répartition  des  tumeurs  était  la  suivante:  méningiomes,  36,4  %, 
craniopharyngiomes, 13,6 % et gliomes, 9,1 %. 67,9 % des patients se plaignaient de troubles visuels à 
l’admission dont 46,6 % avec une baisse importante et 12,5 % une vision double. Il a été objectivé une 
artrophie optique dans 23,9 % . 46 malades (52 %) étaient aveugles et 14 (16 %) avaient un trouble visuel 
important.
Conclusion 
Les troubles visuels sont des manifestations cliniques fréquentes de présentation des tumeurs cérébrales. 
Une information médicale précoce est requise.
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SUMMARY
Background 
This  study was  aimed  at  determining  the  ophthalmic  manifestations  of  patients  presenting  with  brain 
tumours in a Nigerian tertiary hospital.
Method 
A retrospective crossectional review of  patients with brain tumors in the Neurosurgical  Unit  of  Obafemi 
Awolowo  University  Teaching  Hospitals  Complex,  Ile-Ife  from  January  2003  to  December  2007  was 
conducted. Data on biodata, source of referral, diagnosis, visual acuity at presentation and management 
were recorded and analyzed for simple frequency using the SPSS version 11. Visual acuity was classified 
using the WHO classification for presenting acuity in the better eye.
Results 
Out of a total of 94 patients, 88 with complete information were reviewed. There were 53 [60.2%] males and 
35  [39.8%]  females;  the  mean  age  was  36.2±20  years.  Fourteen  [15.9%]  patients  were  referred  by 
Ophthalmologists.  Meningiomas(36.4%),  craniopharyngioma(13.6%)  and  gliomas(9.1%)  were  the  most 
common brain tumours encountered. Fifty nine(67.9%) had visual complains at presentation; poor vision 
(46.6%) and double vision (12.5%) were the most common ocular symptoms while opticatrophy was the 
commonest ocular sign (23.9%). 46 (52%) %) were blind while 14(16%) had visual impairment. Patients 
with visual impairment and blindness were more likely to have visual complains at presentation (88.3%) 
compared with 50% amongst patients with normal vision (P=0.003).
Conclusion 
Ophthalmic signs and symptoms form a major part of presentation in patients with intracranial tumours. 
Health education and complete ophthalmic evaluation is essential in patients with brain tumours.
INTRODUCTION
Primary brain tumours constitute a major reason for seeking neurological consultations worldwide1-3. The 
location and type of  tumour influences the clinical presentation and the management option. The clinical 
features in patients with brain tumours may be caused by their mass or irritating effect, influence on hormone 
secretion/depression or their mass related pressure effect on the surrounding structures or development of 
hydrocephalus4,5 .  Intracranial tumours present with ophthalmic abnormalities; these abnormalities could 
result from their effect on the visual pathway, ocular nerves and orbito-ocular tissues 3,5-11. Ophthalmic 
signs and symptoms in brain tumors include visual loss, double vision, nerve palsy, pupillary abnormalities, 
proptosis and optic nerve head defects; their presentation being largely affected by the type, location and size 
of the of tumors 7. Neuro-ophthalmic involvement of 46.8% - 88.6% have been reported in different series of 
intracranial tumours 3,7,10,11. Visual symptoms and signs form major aspects of presentation in certain 
types of brain tumours and may be of immense help in making appropriate and early diagnosis when initial 
signs are unspecific 7,8,10,12.
Intracranial tumors affect almost any tissue in the brain leading to different spectrum of brain tumours. In a 
study of patients with brain tumours in New York, Snyder at al reported malignant astrocytoma as the most 
frequent tumor 14. Pisarev et al reported gliomas as the commonest brain tumor in the Volgograd region 
where it represented 51.9% of all intracranial tumors13; while in Iran and Thailand, meningiomas were the 
commonest  representing  26% and 45% of  all  brain  tumors  respectively 1,10.  Patients  from  developing 
countries  tend  to  present  late  with  larger  masses  and  this  may  affect  the  prevalence  and  pattern  of 
ophthalmic  manifestations  at  presentation.  The  purpose  of  this  paper  is  to  document  the  ophthalmic 
manifestations of patients presenting with intracranial tumours in a Nigerian tertiary neurosurgical unit.
METHODOLOGY
Setting
The neurosurgical unit of the Obafemi Awolowo University Teaching Hospital, (OAUTHC) Ile-Ife is a referral 
unit for patients with neurosurgery diseases. The unit comanages patients with the Ophthalmology Unit and 
Neurology Unit of the same institution as required. It provides neurosurgical care for Osun, Ondo, Ekiti, Edo 
and Delta States of southwestern and south southern Nigeria being the only centre with such facility (Fig I). 
The unit also treats self  presenting patients to the surgical out-patient clinic as well  as the accident and 
emergency department of the hospital.
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Study design
A 5-year retrospective descriptive review of in-patients managed for intracranial tumors from January 2003 to 
December 2007 was conducted. Patients with intracranial space occupying inflammatory or vascular lesions 
were  excluded.  Preoperative  diagnosis  was  made  based  on  the  clinical  presentation  and  radiological 
investigations. Histological diagnosis was made post operatively. Presenting visual acuity was recorded using 
the Snellen’s chart  or illiterate E chart;  this  was further  classified using the World Health Organizations 
classification into normal, visual impairment, severe visual impairment or blindness; infants were classified as 
blind or believed not to be blind depending on their ability to perceive/follow light and reach out for objects 
presented. The presence or otherwise of visual complains was noted at presentation as well as the duration 
of symptoms prior to presentation. Diagnosis was made following clinical examinations and radiological and 
histological examinations. In patients who did not have surgical treatment, diagnosis was based on clinical 
and radiological examinations. With the aide of a pre-designed questionnaire, the biodata, source of referral, 
diagnosis,  tumour  location,  presenting  visual  acuity,  eye complains  and  radiological  investigations  were 
recorded.  Data  thus  collected  were  analyzed  and  presented  as  frequency  tables  and  percentages  for 
discussion using SPSS version 11.  Comparison between variable  was carried out  with  Chi  square and 
statistical significance inferred at p<0.005.
RESULTS
Out of a total of 94 patients managed for intracranial tumours, 88 with complete records were analyzed.
Socio-demographic distribution
There were 53 [60.2%] males and 35 [39.8%] females with a male to female ratio of 1.5:1. The mean age 
was 36.2±20.1years; 43.2% were within the 36-55 years age group while 19.3% belonged to the peadiatric 
age group (≤ 15 years). Male preponderance was noted across all age groups except in children aged five 
years and below in whom a male to female ratio of 1:1.8 was recorded. Figure I shows the age and sex 
distribution of patients managed for brain tumours. Most of the patients 36 (40.9%) resided within the state of 
location of the neurosurgical facility (Osun State) or 41 (46.6%) within the same zone (southwest). [Table I]
Pattern of referral
Referral was mainly from private hospitals 36(40.9%) while referrals from public hospitals were largely from 
the general outpatient department and emergency rooms of within the same institution 24(27.4%). [Table I] 
Patients had sought previous neurologist 9(10.2%), ophthalmologist 14 (15.9%) and paediatrician 10 (10.4%) 
consultation before presentation. Duration of symptoms prior to neurosurgical attention ranged from 1 to 484 
weeks with a mean of 63.1±107.8 weeks. (52.7%) presented for neurosurgical care more than twelve weeks 
from the onset of symptoms related to the intracranial tumour. [Table I]
Ocular status
59 (67%) had eye complains at presentation while 29(33%) made no complains referable to the eyes. Poor 
vision (46.6%)  and double vision (12.5%)  were  the commonest  ocular  symptoms.  Ocular  findings  were 
normal in 45 (51.3%) patients while optic atrophy was the commonest ocular sign (23.9%). [Table III] Ocular 
nerve palsy was present in 16(18.2%) out of which 9(56.3%) involved the sixth nerve, 5(31.3%) the third 
nerve and 2(12.4%) were multiple nerve palsies. Unilateral blindness was present in 3(3.4%) and unilateral 
visual impairment in 6(6.8%); bilateral blindness was present at presentation in 46 (52%) [Figure II]. Patients 
with  visual  impairment  and  blindness  were  more  likely to  have  eye  complains  at  presentation  (88.3%) 
compared with 50% amongst patients with normal vision using the WHO classification (P=0.003).
Spectrum of intracranial tumours
Radiological investigations conducted were cranial CT scan in 84 [95.5%], MRI in 1[1.1%], and skull X-rays in 
3[3.4%].  Supra-tentorial  tumours  were  more  common  77  [87.5%].  Meningiomas(36.4%), 
Craniopharyngioma(13.6%) and gliomas(9.1%) were the commonest brain tumours encountered (Table III).
DISCUSSION
The mean age of 36.2 years of patients with brain tumour recorded in this study is younger than the 42.8 
years and 50.76 years reported in New York and Romania respectively; it however compares favourably with 
the 33.9 and 37 years reported from Iran and Kenya1,7,14,15. This is obviously a disease affecting mainly 
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young adults  and  middle  aged-  the  economically  and  physically  active  subset  in  any society.  Children 
constituted 19.3% of the patients with brain tumours in this study similar to the 20.1% reported by Mehrazin et 
al1; brain tumors are the most common solid tumour entity in childhood .13 The male preponderance may be 
related to hospital biased design as male utilization of health care facility in sub-saharan African is generally 
reported to be higher than females. The reason for the female predominance in the pediatric age group may 
require further epidemiological  studies as the reason for  this is not known. The signs and symptoms of 
intracranial tumours are usually none specific and may be slowly evolving; this may be responsible for the 
previous consultations before final referral to the neurosurgical unit. Moreover, Cranial Tomography scan is 
not commonly available or affordable by many patients in our environment hence the delay in appropriate 
diagnosis and referral.
The location, size and involvement of the visual pathway and ocular nerves determine to a large extent the 
degree of involvement of the eyes in brain tumours. In this study, about two-thirds (67%) of patients with 
intracranial tumours had ophthalmic symptoms at presentation. This is similar to the slightly higher value of 
72%  reported  by  Marco  et  al  in  Kenya  where  poor  referral  network  and  poverty  leading  to  delayed 
presentation for neurosurgical care were implicated 15. Anderson et al reported a much lower rate of 30% 
among patients with meningiomas 16. Poor vision as the most common ophthalmic symptom in this series is 
similar to previous reports; however, while this symptom was reported in 52% of our patients, much higher 
frequency of 88.6% and 86% were reported 10,11. The difference may be related to the difference in the 
pattern  of  brain  tumours  studied;  meningiomas  and  parasellar  tumors  (pituitary  adenoma  and 
craniopharyngioma) constituted 84.6% of all brain tumours studied as compared to 55.6% in the present 
study. The anatomical  location of  these tumours predisposes them to more frequent mass-compression 
effect on the optic nerve, optic chiasma and optic tract;  hence more frequent involvement of  the vision. 
Ocular  cranial  nerve involvement  is responsible for  double vision which was found in 12.5% of  patients 
studied; this is within range although slightly higher than the 10% reported in Kenya 15. The frequency of 
double  vision  as  a  symptom  may  not  represent  all  the  cases  of  ocular  deviations  and  cranial  nerve 
involvement  as patients with severe visual  impairment  and blindness may not  experience double vision. 
Moreover, young children are not articulate enough to complain of double vision ref. Although 18.2% of the 
patients with intracranial tumours on examination had ocular deviation due to involvement of ocular cranial 
nerves, only 12.5% complained of double vision. Ocular nerves can be affected by intracranial tumour due to 
their  mass  effect  or  infiltration by the tumour.  Although, the third cranial  nerve is  the commonest  palsy 
accompanying  pituitary  tumours,  the  sixth  cranial  nerve  is  frequently  affected  by  the  resultant  raised 
intracranial pressure from intracranial tumours; this is a possible explanation for its commoner occurrence 
compared to the third and fourth nerves in this study.
Over half of our patients were blind at presentation for neurosurgical care; this compares favourable with the 
59% of blindness recorded in Thailand amongst patients with intracranial tumours 10. In a similar study in 
New York,  total percentage of  visual  deficit  reported was 19.8%. The higher percentage of  blindness in 
developing countries as opposed to developed country may be related to late presentation for neurosurgical 
care with larger tumour and in advanced disease in the former. During the period of study, about 59.1% of the 
patients were referred from outside the state of location of the neurosurgical centre. In a developing country 
setting like ours, the adverse effects of poor socio-economic status on health care viz-a- viz utilization and 
late presentation comes to play more when health care facility is located far from the patient.
Optic nerve head changes, that is, optic atrophy and papilloedema were present in 44.4% patients with brain 
tumor in this study. The importance of ophthalmoscopy as part of required neurological examination for early 
diagnosis of intracranial space occupying lesions is further justified. Papilloedema was reported in 27.7% and 
46.8% of patients with intracranial tumours in New York and Romania respectively 7,14. Anteriorly located 
intracranial tumours have a higher propensity to compress the optic pathway and hence present earlier with 
optic nerve compressive changes seen at ophthalmoscopic examinations 15. Visual field defects were the 
commonest ophthalmic sign and were seen in 80.5% of patients with intracranial tumour 12 while Marco et al 
also reported non-specific  field pattern (34%) as the most  common visual  field changes in patients with 
intracranial tumours15. In the present study, this sign was not objectively assessed as visual field analyzer 
was not available in the study centre and its immediate environs.
In conclusion,  ophthalmic  clinical  features form a major  part  of  presentation of  patients with  intracranial 
tumours.  Complete  neuro-ophthalmic  evaluation  seeking  for  the  signs  and  symptoms  enumerated  is 
essential for diagnosis.
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Table I: Characteristic of patients with brain tumours
Characteristics Frequency (%) 
Domicile 
Osun 36(40.9) 




Source of referral 
General outpatient department 16(18.3) 
Tertiary Hospitals 9(10.2) 
Secondary Hospitals 19(21.6) 
Private Hospitals 36(40.9) 
Self (casualty/emergency room) 8(9.1) 
Total 88(100) 
Duration of Symptoms before Presentation 
1-6 weeks 17(18.9) 
7-12 weeks 25(28.4) 
13-17 weeks 6(6.8) 
>/= 18 weeks 40(45.9) 
Total 88(100) 
Table II: Eye symptoms and signs in patients with intracranial tumours
Symptoms Frequency (%) Signs Frequency(%) 
Poor vision 41(46.6) Optic atrophy 21 (23.9) 
Double vision 11(12.5) Anisocoria 20 (22.7) 
Eye ache 3(3.4) Papilloedema 18 (20.5) 
Proptosis 2(2.3) Ocular nerve palsy 16(18.2) 
Drooping lid 2(2.3) Pupillary reaction defect 12 (13.6) 
Eye deviation 1(1.1) Proptosis 10 (11.4) 
Redness 1(1.1) Ptosis 5 (5.7) 
Foster Kennedy Syndrome 2 (2.3) 
Nystagmus 1 (1.1) 
# - multiple signs were present in some patients
http://ajns.paans.org 57
African Journal of Neurological Sciences 2009 - Vol. 28, No 1
Table III: Spectrum of intracranial tumours




Pituitary adenoma 5(5.7) 
Medulloblastoma 5(5.7) 
Pinealoma 4(4.5) 
Cerebellopontine angle tumor 3(3.4) 
Cerebellar tumour 3(3.4) 
Frontal lobe tumour 3(3.4) 
Thalamic tumour 2(2.3) 
Astrocytoma 2(2.3) 





Age and Sex Distribution of Patients with Brain Tumours
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Figure 2
Visual status of patients with intracranial tumours
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